Drug Classification · Questions 1–6
Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.
Question 1
Which of the following drugs is classified as a Vaughan Williams Class One antiarrhythmic agent?
Correct Answer
B — Lidocaine
Rationale
Lidocaine is a Class One antiarrhythmic agent — a sodium channel blocker. Class One agents reduce the rate of rise of phase zero of the cardiac action potential by blocking voltage-gated sodium channels. Amiodarone is a multi-class agent with predominant Class Three activity. Verapamil is a Class Four calcium channel blocker. Metoprolol is a Class Two beta-adrenergic receptor antagonist.
Question 2
A pharmacology student is reviewing antiarrhythmic drug classes. Which of the following correctly identifies the ion channel targeted by Vaughan Williams Class Three antiarrhythmic agents?
Correct Answer
D — Voltage-gated potassium channels
Rationale
Class Three antiarrhythmic agents block voltage-gated potassium channels, prolonging phase 3 repolarization and thereby extending the action potential duration and effective refractory period. Examples include amiodarone, sotalol, dofetilide, and ibutilide. Class One agents target sodium channels; Class Two agents target beta-adrenergic receptors; Class Four agents target calcium channels.
Question 3
Which of the following antiarrhythmic agents is classified outside the Vaughan Williams classification system?
Correct Answer
A — Adenosine
Rationale
Adenosine is an antiarrhythmic agent that does not fit within the Vaughan Williams classification. Other unclassified agents include digoxin and magnesium. The Vaughan Williams system groups drugs by their primary channel or receptor target: Class One (sodium channel blockers), Class Two (beta-blockers), Class Three (potassium channel blockers), and Class Four (calcium channel blockers). Lidocaine is a Class One agent; sotalol is a Class Three agent; verapamil is a Class Four agent.
Question 4
Which of the following drug pairs are both classified as Vaughan Williams Class Four antiarrhythmic agents?
Correct Answer
C — Verapamil and diltiazem
Rationale
Verapamil and diltiazem are the two non-dihydropyridine calcium channel blockers that constitute Vaughan Williams Class Four. They slow conduction through the atrioventricular node and are used for rate control. Lidocaine and mexiletine are Class One (subclass Ib) sodium channel blockers. Amiodarone and sotalol are Class Three potassium channel blockers. Metoprolol and atenolol are Class Two beta-blockers.
Question 5
Which of the following correctly identifies the receptor target of Vaughan Williams Class Two antiarrhythmic agents?
Correct Answer
A — Beta-adrenergic receptors
Rationale
Class Two antiarrhythmic agents are beta-adrenergic receptor antagonists (beta-blockers). By blocking sympathetic stimulation at beta-adrenergic receptors, they reduce heart rate, slow conduction through the atrioventricular node, and suppress catecholamine-driven ectopic automaticity. Examples include metoprolol, atenolol, and propranolol. Muscarinic receptors are targeted by cholinergic agents; alpha-adrenergic receptors fall outside the Vaughan Williams classification targets; adenosine acts at its own receptor and is unclassified.
Question 6
Which of the following antiarrhythmic agents is classified outside the Vaughan Williams system?
Correct Answer
D — Digoxin
Rationale
Digoxin is classified outside the Vaughan Williams system. It exerts its antiarrhythmic effects through a vagotonic (parasympathomimetic) mechanism rather than through direct ion channel blockade. Lidocaine is Class One (sodium channel blocker). Amiodarone is a multi-class agent classified within the system primarily as Class Three. Verapamil is Class Four (calcium channel blocker).
Core Pharmacology · Questions 7–14
Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.
Question 7
During phase 0 of the ventricular action potential, rapid depolarization occurs. Which ion movement is primarily responsible for this phase?
Correct Answer
B — Sodium influx through voltage-gated sodium channels
Rationale
Phase 0 of the ventricular action potential is characterized by rapid depolarization driven by a large inward sodium current through voltage-gated sodium channels. This fast upstroke determines conduction velocity — the speed at which the electrical impulse spreads through the myocardium. Class One antiarrhythmic agents (sodium channel blockers) act at this phase, reducing the rate of rise and slowing conduction. Calcium influx through L-type channels is responsible for phase 2 (the plateau); potassium efflux drives phase 3 (repolarization).
Question 8
Phase 4 of the cardiac action potential differs between pacemaker cells and non-pacemaker cells. Which of the following best describes the distinguishing feature of phase 4 in sinoatrial node pacemaker cells?
Correct Answer
C — A slow spontaneous depolarization driven by inward sodium and calcium currents
Rationale
In sinoatrial node pacemaker cells, phase 4 is not a stable resting potential but rather a slow, spontaneous depolarization — the pacemaker potential. This is driven primarily by the funny current (inward sodium flow through hyperpolarization-activated cyclic nucleotide-gated channels) and a gradual increase in inward calcium current. When the threshold is reached, an action potential fires. This automaticity is absent in non-pacemaker cells (ventricular myocytes), which maintain a stable resting membrane potential during phase 4 due to outward potassium current. Class Two agents (beta-blockers) reduce this spontaneous depolarization rate by opposing sympathetic stimulation.
Question 9
Class One sodium channel blockers demonstrate use-dependent block (also called frequency-dependent block). Which of the following best explains this property?
Correct Answer
A — Drug binding accumulates in rapidly firing tissue because channels spend more time in the open or inactivated state
Rationale
Use-dependent block describes the property by which Class One sodium channel blockers bind preferentially to channels in the open or inactivated state, and the drug-channel complex remains bound when the next action potential arrives in rapidly firing tissue. This means that with each successive action potential, more channels remain blocked — block accumulates with use. Tissue firing rapidly (such as an ectopic focus or reentrant circuit) is therefore more affected than tissue firing at normal rates. This property makes Class One agents selectively effective against tachyarrhythmias without greatly suppressing normal conduction.
Question 10
Many antiarrhythmic drugs work by prolonging the effective refractory period (the minimum time that must pass before a cardiac cell can generate another action potential). Which of the following best explains why prolonging the effective refractory period prevents re-entry arrhythmias?
Correct Answer
D — It closes the excitable gap in the re-entry circuit, preventing the wavefront from propagating
Rationale
Re-entry arrhythmias require three conditions: a loop of tissue, a region of unidirectional block, and an excitable gap — a segment of recovered, re-excitable tissue ahead of the circulating wavefront. When the effective refractory period is prolonged, cells remain refractory for longer, closing this excitable gap. The circulating impulse encounters tissue that cannot yet respond and the circuit extinguishes. Class Three agents (potassium channel blockers such as amiodarone and sotalol) prolong the effective refractory period most reliably by extending phase 3 repolarization and action potential duration.
Question 11
Class Three antiarrhythmic agents prolong action potential duration. Which phase of the cardiac action potential is directly affected by their mechanism of action?
Correct Answer
B — Phase 3 — rapid repolarization
Rationale
Phase 3 repolarization is driven by outward potassium current through delayed rectifier potassium channels. Class Three agents block these channels, slowing the rate of repolarization and prolonging phase 3. This extends the overall action potential duration and, consequently, the effective refractory period. Phase 0 is the target of Class One agents (sodium channel blockade); phase 2 (the plateau) is maintained by calcium influx and is where Class Four agents have their primary effect; phase 4 automaticity is modulated by Class Two agents (beta-blockers).
Question 12
Class Four antiarrhythmic agents slow conduction through the atrioventricular node and are used for rate control. Which of the following best explains the mechanism by which they produce this effect?
Correct Answer
A — Blockade of L-type calcium channels reduces the inward calcium current that drives depolarization in nodal tissue
Rationale
Unlike ventricular myocytes, sinoatrial and atrioventricular nodal cells lack a prominent fast sodium channel upstroke. Their depolarization (phase 0) depends primarily on inward calcium current through L-type calcium channels. Class Four agents — the non-dihydropyridine calcium channel blockers verapamil and diltiazem — block these channels, slowing nodal depolarization, reducing the rate of impulse generation in the sinoatrial node, and prolonging the refractory period of the atrioventricular node. This is the basis of their rate-control effect in atrial fibrillation.
Question 13
Phase 3 of the ventricular action potential is characterized by rapid repolarization back toward the resting membrane potential. Which ion movement is primarily responsible for this phase?
Correct Answer
C — Outward potassium current through delayed rectifier channels
Rationale
Phase 3 repolarization is driven by outward potassium current through delayed rectifier potassium channels. As these channels open and potassium flows out of the cell (down its concentration gradient), the membrane potential returns toward the resting value. This is the phase targeted by Class Three antiarrhythmic agents, which block these channels to prolong repolarization and extend the effective refractory period. Sodium influx drives phase 0; calcium influx sustains the phase 2 plateau; chloride current does not play a primary role in the standard cardiac action potential phases.
Question 14
A re-entry circuit requires three structural and functional conditions to sustain itself. Which of the following correctly identifies all three prerequisites for a re-entry arrhythmia?
Correct Answer
D — A closed loop of tissue, a region of unidirectional block, and an excitable gap ahead of the circulating wavefront
Rationale
Re-entry is the mechanism underlying the majority of sustained tachyarrhythmias, including atrial flutter, atrioventricular nodal reentrant tachycardia, and most ventricular tachycardias. Three conditions must coexist: (1) a closed anatomical or functional circuit — a loop of tissue the impulse can travel around; (2) a zone of unidirectional block — an area that blocks the impulse in one direction but allows it to travel the other way; and (3) an excitable gap — recovered tissue ahead of the circulating wavefront that can be re-excited. Antiarrhythmic drugs terminate re-entry by either closing the excitable gap (Class Three agents prolonging the effective refractory period) or slowing conduction enough to extinguish the circuit (Class One agents). Enhanced automaticity is a separate arrhythmia mechanism, not a re-entry prerequisite.
Clinical Correlations · Questions 15–18
Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.
Question 15
A 62-year-old woman is brought to the emergency department with a heart rate of 148 beats per minute and an irregularly irregular rhythm. An electrocardiogram (a tracing of the heart's electrical activity) confirms atrial fibrillation with rapid ventricular response. The physician decides to use a pharmacological agent to slow the ventricular rate. Which of the following classes of drugs slows ventricular rate in atrial fibrillation by prolonging the refractory period of the atrioventricular node?
Correct Answer
B — Class Four — non-dihydropyridine calcium channel blockers
Rationale
Atrioventricular nodal tissue depends on inward calcium current (through L-type calcium channels) for depolarization rather than fast sodium current. Class Four agents — the non-dihydropyridine calcium channel blockers verapamil and diltiazem — block these channels, directly slowing atrioventricular nodal conduction and prolonging its refractory period. In atrial fibrillation, the atria fire at very high rates, but most impulses are filtered at the atrioventricular node before reaching the ventricles. Blocking calcium channels makes this filtering more effective, reducing how many atrial impulses reach the ventricles and slowing the ventricular rate. Class One agents act on non-nodal tissue (sodium-dependent); Class Three agents prolong the effective refractory period in ventricular myocardium, not specifically the atrioventricular node.
Question 16
A 58-year-old man with persistent atrial fibrillation and no structural heart disease is started on a rhythm control agent. Three weeks later he is in sinus rhythm. His physician explains that the drug works by blocking outward potassium current during phase three repolarization, prolonging the action potential duration and extending the effective refractory period. Which Vaughan Williams class does this drug belong to?
Correct Answer
C — Class Three
Rationale
The drug described belongs to Class Three. Class Three antiarrhythmic agents block voltage-gated potassium channels, slowing phase three repolarization and prolonging both action potential duration and the effective refractory period. This makes re-entry circuits less sustainable. Class One agents block sodium channels. Class Two agents block beta-adrenergic receptors. Class Four agents block calcium channels.
Question 17
A 55-year-old man with a history of hypertension develops frequent premature ventricular contractions (early heartbeats originating from the ventricles) during periods of emotional stress and exercise. His physician explains that increased catecholamine (epinephrine and norepinephrine) levels are likely driving enhanced automaticity in the ventricular tissue by accelerating phase 4 depolarization. Which class of antiarrhythmic agent would most directly suppress this catecholamine-driven automaticity by acting at phase 4?
Correct Answer
A — Class Two — beta-adrenergic receptor antagonists
Rationale
Catecholamines (epinephrine and norepinephrine) stimulate beta-adrenergic receptors, increasing cyclic adenosine monophosphate and enhancing the funny current and calcium entry that drive spontaneous phase 4 depolarization. This accelerates automaticity in both normal pacemaker tissue and ectopic foci. Class Two agents — beta-blockers — block beta-adrenergic receptors and directly counter this effect, slowing the rate of phase 4 depolarization and suppressing catecholamine-induced ectopy. This mechanism explains their particular efficacy in stress- and exercise-triggered arrhythmias. Class One agents slow phase 0 conduction rather than phase 4 automaticity; Class Three agents prolong repolarization; Class Four agents slow nodal calcium-dependent depolarization but do not directly oppose beta-adrenergic stimulation.
Question 18
A 48-year-old man is being treated for a recurrent sustained tachyarrhythmia (an abnormally fast heart rhythm lasting more than 30 seconds) caused by a re-entry circuit in the ventricle. His cardiologist chooses a drug that terminates the arrhythmia by prolonging the effective refractory period of the ventricular myocardium, thereby closing the excitable gap that sustains the re-entry loop. Which Vaughan Williams class produces this effect, and what is the ion channel mechanism?
Correct Answer
D — Class Three — blockade of potassium channels prolongs phase 3 repolarization and extends the effective refractory period
Rationale
Class Three antiarrhythmic agents block delayed rectifier potassium channels, slowing outward potassium current during phase 3. This prolongs repolarization, extends action potential duration, and increases the effective refractory period throughout the ventricular myocardium. A re-entry circuit requires an excitable gap — recovered tissue ahead of the circulating impulse. By lengthening the effective refractory period, Class Three agents close this gap: the wavefront encounters tissue that has not yet recovered and the circuit terminates. Class One agents (sodium channel blockers) can slow conduction in the re-entry circuit but do not primarily prolong the effective refractory period by this mechanism. Class Two agents (beta-blockers) suppress catecholamine-driven automaticity rather than directly closing the excitable gap. Class Four agents (calcium channel blockers) prolong the effective refractory period of nodal tissue, not ventricular myocardium.